NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR)

Historical Holders from Q2 2025 to Q3 2025

Symbol
NKTR on Nasdaq
Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
19,023,727
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
14,405,773
Holdings value
$819,767,110
% of all portfolios
0.01%
Number of holders
142
Number of buys
104
Number of sells
-46
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIOTECHNOLOGY VALUE FUND L P 7.4% $32,978,662 1,276,595 BVF PARTNERS L P/IL 01 Jul 2025
SUSQUEHANNA SECURITIES, LLC 6.3% $70,320,662 1,235,864 Susquehanna Portfolio Strategies, LLC 30 Sep 2025
VANGUARD GROUP INC 4.98% $53,978,014 948,647 The Vanguard Group 30 Sep 2025
INTEGRATED CORE STRATEGIES (US) LLC 3% -48% $32,489,559 -$20,590,346 570,994 -39% Millennium Management LLC 30 Sep 2025
Nantahala Capital Management, LLC 2.2% -59% $23,813,902 -$16,571,499 418,522 -41% Nantahala Capital Management, LLC 30 Sep 2025
BlackRock, Inc. 1.6% $5,245,655 203,017 BlackRock, Inc. 30 Jun 2025

Institutional Holders of NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 14,405,773 $819,767,110 +$415,987,343 $56.9 142
2025 Q2 7,657,053 $197,846,106 +$197,839,388 $25.84 100